A Case of MPGN Caused by MGRS February 10, 2016 By Dallas Nephrology Associates By Nilson Feliz, MD, Manuel Fernandez, MD, Lisa M. Sebastian, MD, Roberto L. Collazo-Maldonado, MD, FACP A 60-year old African American man was referred for evaluation of nephrotic syndrome. His … Continued
Screening for Chronic Kidney Disease February 10, 2016 By Dallas Nephrology Associates By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP and Bernard V. Fischbach, MD, CCRP Chronic kidney disease (CKD) is a general term for diverse disorders affecting kidney structure … Continued
Blood Pressure Management in the Post-SPRINT: The Race Is On February 9, 2016 By Dallas Nephrology Associates By Harold Szerlip, MD MS(ED), FACP, FCCP, FASN, FNKF, CCRP Get ready for a significant change in the hypertension guideline. The SPRINT trial, which compared intensive treatment for hypertension (< … Continued
RDRI Begins First Clinical Trial February 9, 2016 By Dallas Nephrology Associates The Renal Disease Research Institute (RDRI) is a new research entity affiliated with Dallas Nephrology Associates. There is significant ethical oversight of this entity through RDRI’s Board of Managers and … Continued